ANGPT2 and melanoma: To our knowledge, this is the first report to show VEGFC (HR = 0.035; P = 0.031), ANGPT2 (HR = 0.168; P < 0.001), and SIX1 (HR = 0.591; P = 0.009) promoter methylation as prognostic markers for melanoma patient survival.